Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease

Experimental Neurology

Volumn 228, Issue 1, 2011, Pages 80-90

  Kudo, Takashi ^a   Schroeder, Analyne ^a   Loh, Dawn H ^a   Kuljis, Dika ^a   Jordan, Maria C ^a   Roos, Kenneth P ^a   Colwell, Christopher S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autonomic nervous system; BACHD; Circadian rhythm; Heart rate; Huntington's disease; Mouse models of HD; R6 2; Sleep; Suprachiasmatic nucleus

Indexed keywords

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTRIC ACTIVITY; GENE; GENE EXPRESSION; HEART RATE; HUNTINGTON CHOREA; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PERIOD2 GENE; PRIORITY JOURNAL; REGULATORY MECHANISM; RUNNING; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS; THERMOREGULATION;

ANIMALS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; HUNTINGTON DISEASE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY;

EID: 79851513583     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.12.011     Document Type: Article

References (59)

1. Andrich J., Schmitz T., Saft C., Postert T., Kraus P., Epplen J., Przuntek H., Agelink M. Autonomic nervous system function in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2002, 72:726-731.
2. Aziz N., Anguelova G., Marinus J., Lammers G., Roos R. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat. Disord. 2010, 16:345-350.
3. Bär K., Boettger M., Andrich J., Epplen J., Fischer F., Cordes J., Koschke M., Agelink M. Cardiovagal modulation upon postural change is altered in Huntington's disease. Eur. J. Neurol. 2008, 15:869-871.
4. Bigger J.J., Fleiss J., Steinman R., Rolnitzky L., Kleiger R., Rottman J. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992, 85:164-171.
5. Bray M., Shaw C., Moore M., Garcia R., Zanquetta M., Durgan D., Jeong W., Tsai J., Bugger H., Zhang D., Rohrwasser A., Rennison J., Dyck J., Litwin S., Hardin P., Chow C., Chandler M., Abel E., Young M. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1036-H1047.
6. Buccelletti E., Gilardi E., Scaini E., Galiuto L., Persiani R., Biondi A., Basile F., Silveri N. Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur. Rev. Med. Pharmacol. Sci. 2009, 13:299-307.
7. Buijs R., la Fleur S., Wortel J., Van Heyningen C., Zuiddam L., Mettenleiter T., Kalsbeek A., Nagai K., Niijima A. The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J. Comp. Neurol. 2003, 464:36-48.
8. Campbell S.S., Tobler I. Animal sleep: a review of sleep duration across phylogeny. Neurosci. Biobehav. Rev. 1984, 8:269-300.
9. Carruthers S., McCall B., Cordell B., Wu R. Relationships between heart rate and PR interval during physiological and pharmacological interventions. Br. J. Clin. Pharmacol. 1987, 23:259-265.
10. Cepeda C., Cummings D., André V., Holley S., Levine M. Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. ASN Neuro 2010, 2:e00033.
11. Chiu E., Alexander L. Causes of death in Huntington's disease. Med. J. Aust. 1982, 1:153.
12. Colwell C., Michel S., Itri J., Rodriguez W., Tam J., Lelievre V., Hu Z., Liu X., Waschek J. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R939-R949.
13. Colwell C., Michel S., Itri J., Rodriguez W., Tam J., Lelièvre V., Hu Z., Waschek J. Selective deficits in the circadian light response in mice lacking PACAP. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R1194-R1201.
14. Cuturic M., Abramson R., Vallini D., Frank E., Shamsnia M. Sleep patterns in patients with Huntington's disease and their unaffected first-degree relatives: a brief report. Behav. Sleep Med. 2009, 7:245-254.
15. Dragich J., Loh D., Wang L., Vosko A., Kudo T., Nakamura T., Odom I., Tateyama S., Hagopian A., Waschek J., Colwell C. The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus. Eur. J. Neurosci. 2010, 31:864-875.
16. Duff K., Paulsen J., Beglinger L., Langbehn D., Stout J. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 2007, 62:1341-1346. Group, P.-H. I. o. t. H. S.
17. Fahrenkrug J., Popovic N., Georg B., Brundin P., Hannibal J. Decreased VIP and VPAC2 receptor expression in the biological clock of the R6/2 Huntington's disease mouse. J. Mol. Neurosci. 2007, 31:139-148.
18. Feng J., Hu Y., Xie L., Colwell C., Shao X., Sun X., Chen B., Tang H., Campagnoni A. Golli protein negatively regulates store depletion-induced calcium influx in T cells. Immunity 2006, 24:717-727.
19. Gerstner J.R., Lyons L.C., Wright K.P., Loh D.H., Rawashdeh O., Eckel-Mahan K.L., Roman G.W. Cycling behavior and memory formation. J. Neurosci. 2009, 29:12824-12830.
20. Goodman A., Barker R. How vital is sleep in Huntington's disease?. J. Neurol. 2010, 257:882-897.
21. Gray M., Shirasaki D., Cepeda C., André V., Wilburn B., Lu X., Tao J., Yamazaki I., Li S., Sun Y., Li X., Levine M., Yang X. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 2008, 28:6182-6195.
22. Hastings M., Reddy A., Maywood E. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 2003, 4:649-661.
23. Hickey M., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M., Chesselet M. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
24. Itri J., Michel S., Vansteensel M., Meijer J., Colwell C. Fast delayed rectifier potassium current is required for circadian neural activity. Nat. Neurosci. 2005, 8:650-656.
25. Itri J., Vosko A., Schroeder A., Dragich J., Michel S., Colwell C. Circadian regulation of A-type potassium currents in the suprachiasmatic nucleus. J. Neurophysiol. 2010, 103:632-640.
26. Julien C., Thompson J., Wild S., Yardumian P., Snowden J., Turner G., Craufurd D. Psychiatric disorders in preclinical Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:939-943.
27. Kalsbeek A., Perreau-Lenz S., Buijs R. A network of (autonomic) clock outputs. Chronobiol. Int. 2006, 23:521-535.
28. Ko G., Shi L., Ko M. Circadian regulation of ion channels and their functions. J. Neurochem. 2009, 110:1150-1169.
29. Kobal J., Meglic B., Mesec A., Peterlin B. Early sympathetic hyperactivity in Huntington's disease. Eur. J. Neurol. 2004, 11:842-848.
30. Kobal J., Melik Z., Cankar K., Bajrovic F., Meglic B., Peterlin B., Zaletel M. Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease. Acta Neurol. Scand. 2010, 121:392-399.
31. Kremer H., Roos R., Dingjan G., Marani E., Bots G. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J. Neuropathol. Exp. Neurol. 1990, 49:371-382.
32. Kuhlman S., McMahon D. Encoding the ins and outs of circadian pacemaking. J. Biol. Rhythms 2006, 21:470-481.
33. Lanska D., Lavine L., Lanska M., Schoenberg B. Huntington's disease mortality in the United States. Neurology 1988, 38:769-772.
34. Lavin P., Bone I., Sheridan P. Studies of hypothalamic function in Huntington's chorea. J. Neurol. Neurosurg. Psychiatry 1981, 44:414-418.
35. Levine M., Cepeda C., Hickey M., Fleming S., Chesselet M. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci. 2004, 27:691-697.
36. Loh D., Navarro J., Hagopian A., Wang L., Deboer T., Colwell C. Rapid changes in the light/dark cycle disrupt memory of conditioned fear in mice. PLoS ONE 2010, 5.
37. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S., Bates G. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
38. Marcheva B., Ramsey K., Buhr E., Kobayashi Y., Su H., Ko C., Ivanova G., Omura C., Mo S., Vitaterna M., Lopez J., Philipson L., Bradfield C., Crosby S., JeBailey L., Wang X., Takahashi J., Bass J. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
39. Massin M., Maeyns K., Withofs N., Ravet F., Gérard P. Circadian rhythm of heart rate and heart rate variability. Arch. Dis. Child. 2000, 83:179-182.
40. Maywood E., Fraenkel E., McAllister C., Wood N., Reddy A., Hastings M., Morton A. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J. Neurosci. 2010, 30:10199-10204.
41. Menalled L., Sison J., Dragatsis I., Zeitlin S., Chesselet M. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 2003, 465:11-26.
42. Menalled L., El-Khodor B., Patry M., Suárez-Fariñas M., Orenstein S., Zahasky B., Leahy C., Wheeler V., Yang X., MacDonald M., Morton A., Bates G., Leeds J., Park L., Howland D., Signer E., Tobin A., Brunner D. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol. Dis. 2009, 35:319-336.
43. Morton A., Wood N., Hastings M., Hurelbrink C., Barker R., Maywood E. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J. Neurosci. 2005, 25:157-163.
44. Pack A., Galante R., Maislin G., Cater J., Metaxas D., Lu S., Zhang L., Von Smith R., Kay T., Lian J., Svenson K., Peters L. Novel method for high-throughput phenotyping of sleep in mice. Physiol. Genomics 2007, 28:232-238.
45. Pallier P., Maywood E., Zheng Z., Chesham J., Inyushkin A., Dyball R., Hastings M., Morton A. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J. Neurosci. 2007, 27:7869-7878.
46. Petersén A., Gil J., Maat-Schieman M., Björkqvist M., Tanila H., Araújo I., Smith R., Popovic N., Wierup N., Norlén P., Li J., Roos R., Sundler F., Mulder H., Brundin P. Orexin loss in Huntington's disease. Hum. Mol. Genet. 2005, 14:39-47.
47. Reid K., Zee P. Circadian rhythm disorders. Semin. Neurol. 2009, 29:393-405.
48. Schroeder A., Loh D., Jordan M., Roos K., Colwell C. Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide. Am J Physiol Heart Circ Physiol. 2010, Epub Oct 15.
49. Schwartz M., Smale L. Individual differences in rhythms of behavioral sleep and its neural substrates in Nile grass rats. J. Biol. Rhythms 2005, 20:526-537.
50. Soneson C., Fontes M., Zhou Y., Denisov V., Paulsen J., Kirik D., Petersén A. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol. Dis. 2010, 40:531-543. investigators, T. H. S. G. P.-H.
51. Takahashi J., Hong H., Ko C., McDearmon E. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 2008, 9:764-775.
52. Teclemariam-Mesbah R., Kalsbeek A., Pevet P., Buijs R. Direct vasoactive intestinal polypeptide-containing projection from the suprachiasmatic nucleus to spinal projecting hypothalamic paraventricular neurons. Brain Res. 1997, 748:71-76.
53. Thayer J., Yamamoto S., Brosschot J. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int. J. Cardiol. 2010, 141:122-131.
54. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
55. Turek F., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D., Eckel R., Takahashi J., Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
56. Wallick D., Martin P., Masuda Y., Levy M. Effects of autonomic activity and changes in heart rate on atrioventricular conduction. Am. J. Physiol. 1982, 243:H523-H527.
57. Wang L., Dragich J., Kudo T., Odom I., Welsh D., O'Dell T., Colwell C. Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviour. ASN Neuro 2009, 1.
58. Wood N., Goodman A., van der Burg J., Gazeau V., Brundin P., Björkqvist M., Petersén A., Tabrizi S., Barker R., Morton A. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res. Bull. 2008, 76:70-79.
59. Wulff K., Porcheret K., Cussans E., Foster R. Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. Curr. Opin. Genet. Dev. 2009, 19:237-246.